Follow
Maxime Veillette
Maxime Veillette
Verified email at umontreal.ca
Title
Cited by
Cited by
Year
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity
M Veillette, A Désormeaux, H Medjahed, NE Gharsallah, M Coutu, ...
Journal of virology 88 (5), 2633-2644, 2014
2812014
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
1952021
The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals
M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ...
Journal of virology 89 (1), 545-551, 2015
1922015
CD4 mimetics sensitize HIV-1-infected cells to ADCC
J Richard, M Veillette, N Brassard, SS Iyer, M Roger, L Martin, M Pazgier, ...
Proceedings of the National Academy of Sciences 112 (20), E2687-E2694, 2015
1382015
Small CD4 mimetics prevent HIV-1 uninfected bystander CD4+ T cell killing mediated by antibody-dependent cell-mediated cytotoxicity
J Richard, M Veillette, S Ding, D Zoubchenok, N Alsahafi, M Coutu, ...
EBioMedicine 3, 122-134, 2016
782016
Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses
J Richard, M Veillette, LA Batraville, M Coutu, JP Chapleau, M Bonsignori, ...
Journal of virological methods 208, 107-114, 2014
762014
A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies
S Ding, M Veillette, M Coutu, J Prévost, L Scharf, PJ Bjorkman, G Ferrari, ...
Journal of virology 90 (4), 2127-2134, 2016
702016
Co-receptor binding site antibodies enable CD4-mimetics to expose conserved anti-cluster A ADCC epitopes on HIV-1 envelope glycoproteins
J Richard, B Pacheco, N Gohain, M Veillette, S Ding, N Alsahafi, ...
EBioMedicine 12, 208-218, 2016
682016
Immune checkpoint blockade restores HIV-specific CD4 T cell help for NK cells
F Porichis, MG Hart, A Massa, HL Everett, A Morou, J Richard, N Brassard, ...
The Journal of Immunology 201 (3), 971-981, 2018
672018
Influence of the envelope gp120 Phe 43 cavity on HIV-1 sensitivity to antibody-dependent cell-mediated cytotoxicity responses
J Prévost, D Zoubchenok, J Richard, M Veillette, B Pacheco, M Coutu, ...
Journal of virology 91 (7), 10.1128/jvi. 02452-16, 2017
572017
Paring down HIV Env: design and crystal structure of a stabilized inner domain of HIV-1 gp120 displaying a major ADCC target of the A32 region
WD Tolbert, N Gohain, M Veillette, JP Chapleau, C Orlandi, ML Visciano, ...
Structure 24 (5), 697-709, 2016
572016
Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay
M Veillette, M Coutu, J Richard, LA Batraville, A Désormeaux, M Roger, ...
JoVE (Journal of Visualized Experiments), e51995, 2014
502014
Role of HIV-1 envelope glycoproteins conformation and accessory proteins on ADCC responses
M Veillette, J Richard, M Pazgier, G K Lewis, M S Parsons, A Finzi
Current HIV research 14 (1), 9-23, 2016
432016
The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import
M Veillette, K Bichel, P Pawlica, SMV Freund, MB Plourde, QT Pham, ...
Retrovirology 10, 1-14, 2013
352013
Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers
LA Batraville, J Richard, M Veillette, AC Labbé, M Alary, F Guédou, ...
AIDS research and human retroviruses 30 (11), 1145-1149, 2014
312014
Histidine 375 modulates CD4 binding in HIV-1 CRF01_AE envelope glycoproteins
D Zoubchenok, M Veillette, J Prévost, E Sanders-Buell, K Wagh, B Korber, ...
Journal of virology 91 (4), 10.1128/jvi. 02151-16, 2017
262017
Preclinical assessment of mutant human TRIM5α as an anti-HIV-1 transgene
U Jung, K Urak, M Veillette, MÉ Nepveu-Traversy, QT Pham, S Hamel, ...
Human gene therapy 26 (10), 664-679, 2015
222015
A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen
QT Pham, M Veillette, A Brandariz-Nuñez, P Pawlica, C Thibert-Lefebvre, ...
Virus research 173 (2), 306-314, 2013
142013
A putative SUMO interacting motif in the B30. 2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction
MÉ Nepveu-Traversy, A Demogines, T Fricke, MB Plourde, K Riopel, ...
Heliyon 2 (1), 2016
102016
D. 581 E. Kaufmann, M. Roger, and A. Finzi. 2015. The HIV-1 gp120 CD4-bound conformation is 582 preferentially targeted by antibody-dependent cellular cytotoxicity-mediating …
M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ...
J Virol 89, 545-51, 0
6
The system can't perform the operation now. Try again later.
Articles 1–20